+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lung Cancer Diagnostics - Market Analysis, Trends, and Forecasts

  • ID: 4876858
  • Report
  • November 2019
  • Region: Global
  • 605 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbott Diagnostics
  • Biocept, Inc.
  • Circulogene
  • Fulgent Genetics
  • Medgenome Labs Ltd.
  • Pillar Biosciences, Inc.
  • MORE
Lung Cancer Diagnostics market worldwide is projected to grow by US$1.3 Billion, driven by a compounded growth of 8%. Imaging Tests, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.6 Billion by the year 2025, Imaging Tests will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$45.5 Million to the region's size and clout in the next 5 to 6 years. Over US$39.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Imaging Tests will reach a market size of US$85.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.4% over the next couple of years and add approximately US$354.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others:
  • Abbott Diagnostics - Core Laboratory
  • Dr Lal PathLabs
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Myriad Genetics Inc.
  • NanoString Technologies
  • NeoGenomics Laboratories Inc.
  • PlexBio Co., Ltd.
  • QIAGEN GmbH
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Diagnostics
  • Biocept, Inc.
  • Circulogene
  • Fulgent Genetics
  • Medgenome Labs Ltd.
  • Pillar Biosciences, Inc.
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Early Detection of Lung Cancer Takes Precedence, Driving the Demand for Lung Cancer Diagnostics
Non-small Cell Lung Cancer - The More Prominent of the Two Lung Cancer Types
Imaging Tests Segment Dominates the Market, Molecular Tests Category to Witness High Growth
US Leads the Lung Cancer Diagnostics Market, Asia-Pacific to Witness Fastest Growth

2. FOCUS ON SELECT PLAYERS
Agilent Technologies Inc. (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Illumina, Inc. (USA)
NeoGenomics Laboratories, Inc. (USA)
QIAGEN N.V. (The Netherlands)
Thermo Fisher Scientific, Inc. (USA)
Veracyte (USA)

3. MARKET TRENDS & DRIVERS
Increasing Prevalence and Incidence of Lung Cancer to Push the Demand for Early Diagnoses
Age-Standardized Lung Cancer Rates for Select Countries
Age-Standardized Lung Cancer Rates in Men for Select Countries
Age Standardized Lung Cancer Rates in Women for Select Countries
Lung Cancer-Specific Biomarkers to Spur Market Growth
Select Lung Cancer Biomarkers
New Potential Biomarker for Early Stage Lung Cancer Identified in a Recent NCI Study (2019)
Advancements and Research Initiatives Provide Significant Opportunities
EFIRM Test for Detection of Lung Cancer-related EGFR Mutations in NSCLC Patients
A Glance at Select Recent Launches of Lung Cancer Diagnostic Tests
New Product Launches/Approvals in the Lung Cancer Diagnostics
Recent Approvals
Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting Therapy Decisions in NSCLCs
Effervescent Rate of New Innovations & Product Development Will Make Liquid Biopsy a Readily Available Option for Patients in the Coming Years
High Cigarette Consumption/Rise in Prevalence of Smoking Increases the Incidence of Lung Cancer
Cigarette Consumption Per Year Per Person Across Select Countries: 2016
Top 15 Countries with the Highest Smoking Rates: 2015
Increasing Number of Awareness Programs for Lung Cancer and Symptoms
Growing Availability of Government/Private Funding for R&D to Develop Lung Cancer Diagnostics
National Cancer Institute Research Funding for Lung Cancer in US$ Million for the Years 2014 through 2017
Aging Demographics & Unhealthy Lifestyles Raise the Risk of Cancer
Cancer Prone Sites based on Age
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Lung Cancer Diagnostics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 2: Lung Cancer Diagnostics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
TABLE 3: Lung Cancer Diagnostics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Imaging Tests (Test) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 5: Imaging Tests (Test) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 6: Imaging Tests (Test) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Sputum Cytology (Test) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
TABLE 8: Sputum Cytology (Test) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
TABLE 9: Sputum Cytology (Test) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Molecular Tests (Test) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
TABLE 11: Molecular Tests (Test) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
TABLE 12: Molecular Tests (Test) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Biopsy (Test) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
TABLE 14: Biopsy (Test) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
TABLE 15: Biopsy (Test) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Other Tests (Test) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 17: Other Tests (Test) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 18: Other Tests (Test) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Non-Small-Cell Lung Cancer (NSCLC) (Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
TABLE 20: Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017
TABLE 21: Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
TABLE 22: Small-Cell Lung Cancer (SCLC) (Type) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
TABLE 23: Small-Cell Lung Cancer (SCLC) (Type) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017
TABLE 24: Small-Cell Lung Cancer (SCLC) (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 25: Hospital Laboratories (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
TABLE 26: Hospital Laboratories (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017
TABLE 27: Hospital Laboratories (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
TABLE 28: Cancer Research Institutes (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 29: Cancer Research Institutes (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2009-2017
TABLE 30: Cancer Research Institutes (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 31: Other End-Uses (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025
TABLE 32: Other End-Uses (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017
TABLE 33: Other End-Uses (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Lung Cancer Stats
US Lung and Bronchus Cancer New Cases by Gender: 2019E
US Lung and Bronchus Cancer Deaths by Gender: 2019E
Incidence Rates* for Lung and Bronchus Cancer by Gender, 2011-2015
Death Rates* for Lung and Bronchus Cancer by Gender in the US, 2012-2016
Incidence Rates for Lung and Bronchus Cancer by Race/Ethnicity, 2011-2015
Reimbursement and Insurance Coverage for Lung Cancer Screening in the US
CY 2019 Medicare Physician Fee Payment Levels for Low Dose CT Scan (LDCT) Screening
CY 2019 Hospital Outpatient Prospective Payment System (HOPPS) Payment Levels for Low Dose CT Scan (LDCT) Screening
Oncimmune’s EarlyCDT Lung to be commercialized in the US by Biodesix (2019)
Market Analytics
TABLE 34: United States Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2018 to 2025
TABLE 35: Lung Cancer Diagnostics Market in the United States by Test: A Historic Review in US$ Thousand for 2009-2017
TABLE 36: United States Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025
TABLE 37: United States Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
TABLE 38: Lung Cancer Diagnostics Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017
TABLE 39: United States Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 40: United States Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025
TABLE 41: Lung Cancer Diagnostics Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017
TABLE 42: Lung Cancer Diagnostics Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
TABLE 43: Canadian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018 to 2025
TABLE 44: Canadian Lung Cancer Diagnostics Historic Market Review by Test in US$ Thousand: 2009-2017
TABLE 45: Lung Cancer Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Test for 2009, 2019, and 2025
TABLE 46: Canadian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
TABLE 47: Canadian Lung Cancer Diagnostics Historic Market Review by Type in US$ Thousand: 2009-2017
TABLE 48: Lung Cancer Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 49: Canadian Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025
TABLE 50: Lung Cancer Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017
TABLE 51: Canadian Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
TABLE 52: Japanese Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2018-2025
TABLE 53: Lung Cancer Diagnostics Market in Japan: Historic Sales Analysis in US$ Thousand by Test for the Period 2009-2017
TABLE 54: Japanese Lung Cancer Diagnostics Market Share Analysis by Test: 2009 VS 2019 VS 2025
TABLE 55: Japanese Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
TABLE 56: Lung Cancer Diagnostics Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
TABLE 57: Japanese Lung Cancer Diagnostics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 58: Japanese Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025
TABLE 59: Japanese Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2009-2017
TABLE 60: Lung Cancer Diagnostics Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
CHINA
TABLE 61: Chinese Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2018-2025  
TABLE 62: Lung Cancer Diagnostics Historic Market Analysis in China in US$ Thousand by Test: 2009-2017  
TABLE 63: Chinese Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 64: Chinese Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025  
TABLE 65: Lung Cancer Diagnostics Historic Market Analysis in China in US$ Thousand by Type: 2009-2017  
TABLE 66: Chinese Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 67: Chinese Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025  
TABLE 68: Lung Cancer Diagnostics Market Review in China in US$ Thousand by End-Use: 2009-2017  
TABLE 69: Chinese Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025  
EUROPE  
TABLE 70: European Lung Cancer Diagnostics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025  
TABLE 71: Lung Cancer Diagnostics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017  
TABLE 72: European Lung Cancer Diagnostics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025  
TABLE 73: European Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018-2025  
TABLE 74: Lung Cancer Diagnostics Market in Europe in US$ Thousand by Test: A Historic Review for the Period 2009-2017  
TABLE 75: European Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 76: European Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025  
TABLE 77: Lung Cancer Diagnostics Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017  
TABLE 78: European Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 79: European Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025  
TABLE 80: Lung Cancer Diagnostics Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017  
TABLE 81: European Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025  
FRANCE  
TABLE 82: Lung Cancer Diagnostics Market in France by Test: Estimates and Projections in US$ Thousand for the Period 2018-2025  
TABLE 83: French Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Test: 2009-2017  
TABLE 84: French Lung Cancer Diagnostics Market Share Analysis by Test: 2009 VS 2019 VS 2025  
TABLE 85: Lung Cancer Diagnostics Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025  
TABLE 86: French Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Type: 2009-2017  
TABLE 87: French Lung Cancer Diagnostics Market Share Analysis by Type: 2009 VS 2019 VS 2025  
TABLE 88: Lung Cancer Diagnostics Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025  
TABLE 89: French Lung Cancer Diagnostics Historic Market Review in US$ Thousand by End-Use: 2009-2017  
TABLE 90: French Lung Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025  
GERMANY
TABLE 91: Lung Cancer Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2018-2025  
TABLE 92: German Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2009-2017  
TABLE 93: German Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 94: Lung Cancer Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025  
TABLE 95: German Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2009-2017  
TABLE 96: German Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 97: Lung Cancer Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025  
TABLE 98: German Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2009-2017  
TABLE 99: Lung Cancer Diagnostics Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025  
ITALY
TABLE 100: Italian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2018-2025  
TABLE 101: Lung Cancer Diagnostics Historic Market Analysis in Italy in US$ Thousand by Test: 2009-2017  
TABLE 102: Italian Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 103: Italian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025  
TABLE 104: Lung Cancer Diagnostics Historic Market Analysis in Italy in US$ Thousand by Type: 2009-2017  
TABLE 105: Italian Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 106: Italian Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025  
TABLE 107: Lung Cancer Diagnostics Market Review in Italy in US$ Thousand by End-Use: 2009-2017  
TABLE 108: Italian Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025  
UNITED KINGDOM
UK Age-standardised Rate (per 100,00) of Lung Cancer Cases by Gender: 1980-2035P  
TABLE 109: United Kingdom Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2018-2025  
TABLE 110: Lung Cancer Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Test for the Period 2009-2017  
TABLE 111: United Kingdom Lung Cancer Diagnostics Market Share Analysis by Test: 2009 VS 2019 VS 2025  
TABLE 112: United Kingdom Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025  
TABLE 113: Lung Cancer Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017  
TABLE 114: United Kingdom Lung Cancer Diagnostics Market Share Analysis by Type: 2009 VS 2019 VS 2025  
TABLE 115: United Kingdom Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025  
TABLE 116: United Kingdom Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2009-2017  
TABLE 117: Lung Cancer Diagnostics Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025  
SPAIN  
TABLE 118: Spanish Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018 to 2025  
TABLE 119: Spanish Lung Cancer Diagnostics Historic Market Review by Test in US$ Thousand: 2009-2017  
TABLE 120: Lung Cancer Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Test for 2009, 2019, and 2025  
TABLE 121: Spanish Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025  
TABLE 122: Spanish Lung Cancer Diagnostics Historic Market Review by Type in US$ Thousand: 2009-2017  
TABLE 123: Lung Cancer Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025  
TABLE 124: Spanish Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025  
TABLE 125: Lung Cancer Diagnostics Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017  
TABLE 126: Spanish Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025  
RUSSIA  
TABLE 127: Russian Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2018 to 2025  
TABLE 128: Lung Cancer Diagnostics Market in Russia by Test: A Historic Review in US$ Thousand for 2009-2017  
TABLE 129: Russian Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 130: Russian Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025  
TABLE 131: Lung Cancer Diagnostics Market in Russia by Type: A Historic Review in US$ Thousand for 2009-2017  
TABLE 132: Russian Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 133: Russian Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025  
TABLE 134: Lung Cancer Diagnostics Historic Demand Patterns in Russia by End-Use in US$ Thousand for 2009-2017  
TABLE 135: Lung Cancer Diagnostics Market Share Breakdown in Russia by End-Use: 2009 VS 2019 VS 2025  
REST OF EUROPE  
TABLE 136: Rest of Europe Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018-2025  
TABLE 137: Lung Cancer Diagnostics Market in Rest of Europe in US$ Thousand by Test: A Historic Review for the Period 2009-2017  
TABLE 138: Rest of Europe Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 139: Rest of Europe Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025  
TABLE 140: Lung Cancer Diagnostics Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017  
TABLE 141: Rest of Europe Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 142: Rest of Europe Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025  
TABLE 143: Lung Cancer Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017  
TABLE 144: Rest of Europe Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025  
ASIA-PACIFIC  
TABLE 145: Asia-Pacific Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025  
TABLE 146: Lung Cancer Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017  
TABLE 147: Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025  
TABLE 148: Lung Cancer Diagnostics Market in Asia-Pacific by Test: Estimates and Projections in US$ Thousand for the Period 2018-2025  
TABLE 149: Asia-Pacific Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Test: 2009-2017  
TABLE 150: Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Test: 2009 VS 2019 VS 2025  
TABLE 151: Lung Cancer Diagnostics Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025  
TABLE 152: Asia-Pacific Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Type: 2009-2017  
TABLE 153: Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Type: 2009 VS 2019 VS 2025 
TABLE 154: Lung Cancer Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025  
TABLE 155: Asia-Pacific Lung Cancer Diagnostics Historic Market Review in US$ Thousand by End-Use: 2009-2017  
TABLE 156: Asia-Pacific Lung Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025  
AUSTRALIA  
TABLE 157: Lung Cancer Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2018-2025  
TABLE 158: Australian Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2009-2017  
TABLE 159: Australian Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 160: Lung Cancer Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025  
TABLE 161: Australian Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2009-2017  
TABLE 162: Australian Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 163: Lung Cancer Diagnostics Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025  
TABLE 164: Australian Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2009-2017  
TABLE 165: Lung Cancer Diagnostics Market Share Distribution in Australia by End-Use: 2009 VS 2019 VS 2025  
INDIA  
Rise in Incidence of Lung Cancer in India  
New Cancer Cases in India by Site: 2018  
Market Analytics  
TABLE 166: Indian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018 to 2025  
TABLE 167: Indian Lung Cancer Diagnostics Historic Market Review by Test in US$ Thousand: 2009-2017  
TABLE 168: Lung Cancer Diagnostics Market in India: Percentage Share Breakdown of Sales by Test for 2009, 2019, and 2025  
TABLE 169: Indian Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025  
TABLE 170: Indian Lung Cancer Diagnostics Historic Market Review by Type in US$ Thousand: 2009-2017  
TABLE 171: Lung Cancer Diagnostics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025  
TABLE 172: Indian Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025  
TABLE 173: Lung Cancer Diagnostics Market in India: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017  
TABLE 174: Indian Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025  
SOUTH KOREA  
TABLE 175: Lung Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2018-2025  
TABLE 176: South Korean Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2009-2017  
TABLE 177: Lung Cancer Diagnostics Market Share Distribution in South Korea by Test: 2009 VS 2019 VS 2025  
TABLE 178: Lung Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025  
TABLE 179: South Korean Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2009-2017  
TABLE 180: Lung Cancer Diagnostics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025  
TABLE 181: Lung Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2018-2025  
TABLE 182: South Korean Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by End-Use: 2009-2017  
TABLE 183: Lung Cancer Diagnostics Market Share Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025  
REST OF ASIA-PACIFIC  
TABLE 184: Rest of Asia-Pacific Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2018-2025  
TABLE 185: Lung Cancer Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Test for the Period 2009-2017  
TABLE 186: Rest of Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Test: 2009 VS 2019 VS 2025  
TABLE 187: Rest of Asia-Pacific Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025  
TABLE 188: Lung Cancer Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017  
TABLE 189: Rest of Asia-Pacific Lung Cancer Diagnostics Market Share Analysis by Type: 2009 VS 2019 VS 2025  
TABLE 190: Rest of Asia-Pacific Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025  
TABLE 191: Rest of Asia-Pacific Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2009-2017  
TABLE 192: Lung Cancer Diagnostics Market Share Shift in Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025  
LATIN AMERICA  
TABLE 193: Latin American Lung Cancer Diagnostics Market Trends by Region/Country in US$ Thousand: 2018-2025  
TABLE 194: Lung Cancer Diagnostics Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017  
TABLE 195: Latin American Lung Cancer Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025  
TABLE 196: Latin American Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2018-2025  
TABLE 197: Lung Cancer Diagnostics Historic Market Analysis in Latin America in US$ Thousand by Test: 2009-2017  
TABLE 198: Latin American Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 199: Latin American Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025  
TABLE 200: Lung Cancer Diagnostics Historic Market Analysis in Latin America in US$ Thousand by Type: 2009-2017  
TABLE 201: Latin American Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 202: Latin American Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025  
TABLE 203: Lung Cancer Diagnostics Market Review in Latin America in US$ Thousand by End-Use: 2009-2017  
TABLE 204: Latin American Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025  
ARGENTINA  
TABLE 205: Argentinean Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018-2025  
TABLE 206: Lung Cancer Diagnostics Market in Argentina in US$ Thousand by Test: A Historic Review for the Period 2009-2017  
TABLE 207: Argentinean Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 208: Argentinean Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025  
TABLE 209: Lung Cancer Diagnostics Market in Argentina in US$ Thousand by Type: A Historic Review for the Period 2009-2017  
TABLE 210: Argentinean Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 211: Argentinean Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025  
TABLE 212: Lung Cancer Diagnostics Market in Argentina: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017  
TABLE 213: Argentinean Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025  
BRAZIL  
TABLE 214: Lung Cancer Diagnostics Market in Brazil by Test: Estimates and Projections in US$ Thousand for the Period 2018-2025  
TABLE 215: Brazilian Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Test: 2009-2017  
TABLE 216: Brazilian Lung Cancer Diagnostics Market Share Analysis by Test: 2009 VS 2019 VS 2025  
TABLE 217: Lung Cancer Diagnostics Market in Brazil by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025  
TABLE 218: Brazilian Lung Cancer Diagnostics Historic Market Scenario in US$ Thousand by Type: 2009-2017  
TABLE 219: Brazilian Lung Cancer Diagnostics Market Share Analysis by Type: 2009 VS 2019 VS 2025  
TABLE 220: Lung Cancer Diagnostics Quantitative Demand Analysis in Brazil in US$ Thousand by End-Use: 2018-2025  
TABLE 221: Brazilian Lung Cancer Diagnostics Historic Market Review in US$ Thousand by End-Use: 2009-2017  
TABLE 222: Brazilian Lung Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025  
MEXICO  
TABLE 223: Lung Cancer Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2018-2025  
TABLE 224: Mexican Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2009-2017  
TABLE 225: Mexican Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 226: Lung Cancer Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025  
TABLE 227: Mexican Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2009-2017  
TABLE 228: Mexican Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 229: Lung Cancer Diagnostics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025  
TABLE 230: Mexican Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2009-2017  
TABLE 231: Lung Cancer Diagnostics Market Share Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025  
REST OF LATIN AMERICA  
TABLE 232: Rest of Latin America Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2018 to 2025  
TABLE 233: Lung Cancer Diagnostics Market in Rest of Latin America by Test: A Historic Review in US$ Thousand for 2009-2017  
TABLE 234: Rest of Latin America Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 235: Rest of Latin America Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025  
TABLE 236: Lung Cancer Diagnostics Market in Rest of Latin America by Type: A Historic Review in US$ Thousand for 2009-2017  
TABLE 237: Rest of Latin America Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 238: Rest of Latin America Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025  
TABLE 239: Lung Cancer Diagnostics Historic Demand Patterns in Rest of Latin America by End-Use in US$ Thousand for 2009-2017  
TABLE 240: Lung Cancer Diagnostics Market Share Breakdown in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025  
MIDDLE EAST  
TABLE 241: The Middle East Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025  
TABLE 242: Lung Cancer Diagnostics Market in the Middle East by Region/Country in US$ Thousand: 2009-2017  
TABLE 243: The Middle East Lung Cancer Diagnostics Market Share Breakdown by Region/Country: 2009, 2019, and 2025  
TABLE 244: The Middle East Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018 to 2025  
TABLE 245: The Middle East Lung Cancer Diagnostics Historic Market by Test in US$ Thousand: 2009-2017  
TABLE 246: Lung Cancer Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Test for 2009, 2019, and 2025  
TABLE 247: The Middle East Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025  
TABLE 248: The Middle East Lung Cancer Diagnostics Historic Market by Type in US$ Thousand: 2009-2017  
TABLE 249: Lung Cancer Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025  
TABLE 250: The Middle East Lung Cancer Diagnostics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025  
TABLE 251: Lung Cancer Diagnostics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017  
TABLE 252: The Middle East Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025  
IRAN  
TABLE 253: Iranian Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Test for the Period 2018-2025  
TABLE 254: Lung Cancer Diagnostics Market in Iran: Historic Sales Analysis in US$ Thousand by Test for the Period 2009-2017  
TABLE 255: Iranian Lung Cancer Diagnostics Market Share Analysis by Test: 2009 VS 2019 VS 2025  
TABLE 256: Iranian Market for Lung Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025  
TABLE 257: Lung Cancer Diagnostics Market in Iran: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017  
TABLE 258: Iranian Lung Cancer Diagnostics Market Share Analysis by Type: 2009 VS 2019 VS 2025  
TABLE 259: Iranian Demand Estimates and Forecasts for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025  
TABLE 260: Iranian Lung Cancer Diagnostics Market in US$ Thousand by End-Use: 2009-2017  
TABLE 261: Lung Cancer Diagnostics Market Share Shift in Iran by End-Use: 2009 VS 2019 VS 2025  
ISRAEL  
TABLE 262: Israeli Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Test: 2018-2025  
TABLE 263: Lung Cancer Diagnostics Market in Israel in US$ Thousand by Test: A Historic Review for the Period 2009-2017  
TABLE 264: Israeli Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 265: Israeli Lung Cancer Diagnostics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025  
TABLE 266: Lung Cancer Diagnostics Market in Israel in US$ Thousand by Type: A Historic Review for the Period 2009-2017  
TABLE 267: Israeli Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 268: Israeli Lung Cancer Diagnostics Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025  
TABLE 269: Lung Cancer Diagnostics Market in Israel: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017  
TABLE 270: Israeli Lung Cancer Diagnostics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025  
SAUDI ARABIA  
TABLE 271: Saudi Arabian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Test for the Period 2018-2025  
TABLE 272: Lung Cancer Diagnostics Historic Market Analysis in Saudi Arabia in US$ Thousand by Test: 2009-2017  
TABLE 273: Saudi Arabian Lung Cancer Diagnostics Market by Test: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 274: Saudi Arabian Lung Cancer Diagnostics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025  
TABLE 275: Lung Cancer Diagnostics Historic Market Analysis in Saudi Arabia in US$ Thousand by Type: 2009-2017  
TABLE 276: Saudi Arabian Lung Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025  
TABLE 277: Saudi Arabian Demand for Lung Cancer Diagnostics in US$ Thousand by End-Use: 2018 to 2025  
TABLE 278: Lung Cancer Diagnostics Market Review in Saudi Arabia in US$ Thousand by End-Use: 2009-2017  
TABLE 279: Saudi Arabian Lung Cancer Diagnostics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025  
UNITED ARAB EMIRATES  
TABLE 280: Lung Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2018-2025  
TABLE 281: United Arab Emirates Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2009-2017  
TABLE 282: Lung Cancer Diagnostics Market Share Distribution in United Arab Emirates by Test: 2009 VS 2019 VS 2025  
TABLE 283: Lung Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025  
TABLE 284: United Arab Emirates Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2009-2017  
TABLE 285: Lung Cancer Diagnostics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025  
TABLE 286: Lung Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2018-2025  
TABLE 287: United Arab Emirates Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by End-Use: 2009-2017  
TABLE 288: Lung Cancer Diagnostics Market Share Distribution in United Arab Emirates by End-Use: 2009 VS 2019 VS 2025  
REST OF MIDDLE EAST  
TABLE 289: Lung Cancer Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Test for the Period 2018-2025  
TABLE 290: Rest of Middle East Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Test: 2009-2017  
TABLE 291: Rest of Middle East Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 292: Lung Cancer Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025  
TABLE 293: Rest of Middle East Lung Cancer Diagnostics Historic Market Analysis in US$ Thousand by Type: 2009-2017  
TABLE 294: Rest of Middle East Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 295: Lung Cancer Diagnostics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025  
TABLE 296: Rest of Middle East Lung Cancer Diagnostics Market in Retrospect in US$ Thousand by End-Use: 2009-2017  
TABLE 297: Lung Cancer Diagnostics Market Share Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025  
AFRICA  
TABLE 298: African Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Test: 2018 to 2025  
TABLE 299: Lung Cancer Diagnostics Market in Africa by Test: A Historic Review in US$ Thousand for 2009-2017  
TABLE 300: African Lung Cancer Diagnostics Market Share Breakdown by Test: 2009 VS 2019 VS 2025  
TABLE 301: African Lung Cancer Diagnostics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025  
TABLE 302: Lung Cancer Diagnostics Market in Africa by Type: A Historic Review in US$ Thousand for 2009-2017  
TABLE 303: African Lung Cancer Diagnostics Market Share Breakdown by Type: 2009 VS 2019 VS 2025  
TABLE 304: African Lung Cancer Diagnostics Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025  
TABLE 305: Lung Cancer Diagnostics Historic Demand Patterns in Africa by End-Use in US$ Thousand for 2009-2017  
TABLE 306: Lung Cancer Diagnostics Market Share Breakdown in Africa by End-Use: 2009 VS 2019 VS 2025  

IV. COMPETITION  
ABBOTT DIAGNOSTICS - CORE LABORATORY  
ADMERA HEALTH  
AGENA BIOSCIENCE, INC.  
AGILENT TECHNOLOGIES, INC.  
ASURAGEN, INC.  
BGI GENOMICS CO., LTD.  
BIOCARTIS NV  
BIOCEPT, INC.  
BIODESIX, INC.  
BIOPROGNOS SL  
BLUEPRINT GENETICS OY  
CANCER GENETICS, INC.  
CELLMAX LIFE, INC.  
CELLNETIX PATHOLOGY & LABORATORIES  
CIRCULOGENE  
DR LAL PATHLABS  
ENTROGEN, INC.  
EPIGENOMICS AG  
EXACT SCIENCES CORPORATION  
EXOSOME DIAGNOSTICS, INC.  
F. HOFFMANN-LA ROCHE LTD.  
ROCHE DIAGNOSTICS  
FULGENT GENETICS  
GENEKOR MEDICAL SA  
GUARDANT HEALTH, INC.  
ILLUMINA, INC.  
IMMUNOVIA AB  
INIVATA LTD.  
LUCENCE DIAGNOSTICS PTE LTD.  
MEDGENOME LABS LTD.  
MYRIAD GENETICS, INC.  
NANOSTRING TECHNOLOGIES, INC.  
NEOGENOMICS LABORATORIES, INC.  
ONCIMMUNE LTD.  
ONCOCYTE CORPORATION  
ONCODNA SA  
PARAGON GENOMICS, INC.  
PILLAR BIOSCIENCES, INC.  
PLEXBIO CO., LTD.  
QIAGEN GMBH  
QUEST DIAGNOSTICS, INC.  
SAVICELL DIAGNOSTIC LTD.  
STAGEZERO LIFE SCIENCES, LLC  
STRAND LIFE SCIENCES PVT. LTD.  
SWIFT BIOSCIENCES, INC.  
SYSMEX INOSTICS, INC.  
SYSMEX EUROPE GMBH  
THERMO FISHER SCIENTIFIC, INC.

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Diagnostics
  • Admera Health  
  • Agena Bioscience, Inc.  
  • Agilent Technologies, Inc.  
  • Asuragen, Inc.  
  • Bgi Genomics Co., Ltd.  
  • Biocartis Nv  
  • Biocept, Inc.  
  • Biodesix, Inc.  
  • Bioprognos Sl  
  • Blueprint Genetics Oy  
  • Cancer Genetics, Inc.  
  • Cellmax Life, Inc.  
  • Cellnetix Pathology & Laboratories  
  • Circulogene  
  • Dr Lal Pathlabs  
  • Entrogen, Inc.  
  • Epigenomics Ag  
  • Exact Sciences Corporation  
  • Exosome Diagnostics, Inc.  
  • F. Hoffmann-La Roche Ltd.  
  • Roche Diagnostics  
  • Fulgent Genetics  
  • Genekor Medical Sa  
  • Guardant Health, Inc.  
  • Illumina, Inc.  
  • Immunovia Ab  
  • Inivata Ltd.  
  • Lucence Diagnostics Pte Ltd.  
  • Medgenome Labs Ltd.  
  • Myriad Genetics, Inc.  
  • Nanostring Technologies, Inc.  
  • Neogenomics Laboratories, Inc.  
  • Oncimmune Ltd.  
  • Oncocyte Corporation  
  • Oncodna Sa  
  • Paragon Genomics, Inc.  
  • Pillar Biosciences, Inc.  
  • Plexbio Co., Ltd.  
  • Qiagen Gmbh  
  • Quest Diagnostics, Inc.  
  • Savicell Diagnostic Ltd.  
  • Stagezero Life Sciences, Llc  
  • Strand Life Sciences Pvt. Ltd.  
  • Swift Biosciences, Inc.  
  • Sysmex Inostics, Inc.  
  • Sysmex Europe Gmbh  
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll